Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 2648  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
  »  Article in PDF (469 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

  In this Article
 »  References

 Article Access Statistics
    PDF Downloaded25    
    Comments [Add]    
    Cited by others 4    

Recommend this journal


Table of Contents    
Year : 2019  |  Volume : 67  |  Issue : 4  |  Page : 1142

Cyclooxygenase-2 Gene Polymorphisms and Risk of Alzheimer's Disease: A Possible Biomoleular Explanation

1 Medical Center, Sanitation, Medical Academic Center, Bangkok, Thailand
2 Visiting Professor, Hainan Medical University, Haikou, China

Date of Web Publication10-Sep-2019

Correspondence Address:
Dr. Beuy Joob
Sanitation, Medical Academic Center, Bangkok
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0028-3886.266266

Rights and Permissions

How to cite this article:
Joob B, Wiwanitkit V. Cyclooxygenase-2 Gene Polymorphisms and Risk of Alzheimer's Disease: A Possible Biomoleular Explanation. Neurol India 2019;67:1142

How to cite this URL:
Joob B, Wiwanitkit V. Cyclooxygenase-2 Gene Polymorphisms and Risk of Alzheimer's Disease: A Possible Biomoleular Explanation. Neurol India [serial online] 2019 [cited 2022 Jan 24];67:1142. Available from:


Cyclooxygenase-2 (COX-2) is an important enzyme for the synthesis of prostaglandins bioprocess. COX-2 plays a role in inflammation response. There are many reports regarding the relationship between COX-2 and the pathogenesis of Alzheimer's disease (AD). In a recent meta-analysis study by Luo et al., it was concluded that “C-allele of rs20417 (-765G>C) polymorphism was associated with a reduced risk of AD, which might be a protective factor.”[1] Here, the authors used the basic quantum calculation for determining the molecular weight change in G to C type and found that there was a reduction from 151.13 to 111.1. The molecular weight reduction can imply that more energy is required for the biological process of final enzyme reaction or increased difficulty for COX-2 expression. This is concordant with the finding that increased expression of COX-2 was observed in cases with severe AD.[2] In fact, the phenomenon is the same as the molecular weight change described by quantum calculation study in previous reports on disease-related polymorphisms.[3],[4] Hence, the effect of COX-2 polymorphism on AD susceptibility can be confirmed. Nevertheless, it should be noted that there are other genes polymorphisms that might affect the susceptibility for AD. A good example is phospholipase A2 enzyme gene.[5] Clarifying the combinatorial effect among different gene polymorphisms on the susceptibility of AD is very interesting.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

 » References Top

Luo D, Long Y, Chen GJ. Cyclooxygenase-2 gene polymorphisms and risk of Alzheimer's disease: A meta-analysis. J Neurol Sci 2015;359:100-5.  Back to cited text no. 1
Ho L, Purohit D, Haroutunian V, Luterman JD, Willis F, Naslund J, et al. Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch Neurol 2001;58:487-92.s.  Back to cited text no. 2
Joob B, Wiwanitkit V. HSD11B1 rs846908 polymorphisms and tacrolimus concentrations: Quantum chemical analysis and implication in patients with renal transplantation. J Nephropharmacol 2016;6:19-20.  Back to cited text no. 3
Joob B, Wiwanitkit V. ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1) polymorphism and clopidogrel concentration in acute coronary syndrome: Molecular change can explain the observed therapeutic concentration. Anatol J Cardiol 2016;16:303-4.  Back to cited text no. 4
Cordeiro Q, Noguti R, Bottino CM, Vallada H. Study of association between genetic polymorphisms of phospholipase A2 enzymes and Alzheimer's disease. Arq Neuropsiquiatr 2010;68:189-93.  Back to cited text no. 5

This article has been cited by
1 Nutraceutical and therapeutic potential of Phycocyanobilin for treating Alzheimer’s disease
Beatriz Piniella-Matamoros, Javier Marín-Prida, Giselle Pentón-Rol
Journal of Biosciences. 2021; 46(2)
[Pubmed] | [DOI]
2 High Prevalence and Low Awareness of Mild Cognitive Impairment in a Suburban Community in Shanghai
Juan Yang, Xiaohui Zhao, Haijing Sui, Xueyuan Liu
Neurology India. 2021; 69(6): 1693
[Pubmed] | [DOI]
3 Cyclooxygenase-2 Gene Polymorphisms – 765G>C and –1195A>G and Mycosis Fungoides
Beuy Joob, Viroj Wiwanitkti
Dermatology. 2020; 236(4): 323
[Pubmed] | [DOI]
4 The Genetics of Alzheimer’s Disease in the Chinese Population
Chen-Ling Gan, Tao Zhang, Tae Ho Lee
International Journal of Molecular Sciences. 2020; 21(7): 2381
[Pubmed] | [DOI]


Print this article  Email this article
Online since 20th March '04
Published by Wolters Kluwer - Medknow